Dr. Turkin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
635 Maple Ave
Du Bois, PA 15801Phone+1 814-375-6379Fax+1 814-375-9320
Education & Training
- Allegheny Health Network Medical Education Consortium (AGH)Residency, Psychiatry, 1993 - 1996
- Allegheny Health Network Medical Education Consortium (AGH)Internship, Internal Medicine, 1992 - 1993
- Popular Autonomous University of Puebla State School of MedicineClass of 1990
Certifications & Licensure
- PA State Medical License 1993 - 2024
- CA State Medical License 1983 - 1984
- American Board of Psychiatry and Neurology Psychiatry
Awards, Honors, & Recognition
- distinguished fellow american psychiatric association
Publications & Presentations
PubMed
- 130 citationsReplicable differences in preferred circadian phase between bipolar disorder patients and control individualsJoel Wood, Boris Birmaher, David Axelson, Mary Ehmann, Catherine Kalas
Psychiatry Research. 2009-04-30 - 335 citationsMetabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians.Andrea Fagiolini, Ellen Frank, John Scott, Scott R. Turkin, David J. Kupfer
Bipolar Disorders. 2005-10-01 - 23 citationsEnhancing outcomes in patients with bipolar disorder: results from the Bipolar Disorder Center for Pennsylvanians StudyAndrea Fagiolini, Ellen Frank, David Axelson, Boris Birmaher, Yu Cheng
Bipolar Disorders. 2009-06-01
Journal Articles
- a pilot, 15 month randomised effectiveness trial of risperidone long-acting injection versus oral atypical antipsychotic agents in persons with bipolar disorderchengappa, k n roy;turkins, scott r; schlicht, patricia j; murphy, sherry l; brar, jaspreet s; fagiolini,a;houck, patricia a; garbutt, ronald g; fredrick, noreen, acta neuropsychiatrica vol 22 issue 2 april 2010
Press Mentions
- (Ashwagandha) to Treat Symptom Exacerbation in Schizophrenia:July 10th, 2018
Committees
- member, government relations committee, pennsylvania psychiatric society
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: